Actualités et Activités de Pharming
Dirigeants
Voir l'organigramme avec ses 35 principaux dirigeants
Biographies les plus recherchées chez Pharming
- Fabrice Chouraqui, Executive Director and Chief Executive Officer
- Jabine Van Der Meijs, Director
- Richard Peters, Chairman of the Board
Changements de dirigeants chez Pharming
- Michael Levitan qui était Vice President, Investor Relations and Corporate Communications, devient Vice President, Investor Relations and Capital Markets (publié le 19 juin 2026).
- Leverne Marsh, a rejoint l'entreprise comme President, Chief Commercial Officer (publié le 5 février 2026).
Créer une alerte
pour suivre les mouvements de dirigeants chez Pharming.
Biotechnologie
Pharming a 2 428 concurrents dont Lonza (Suisse), Vertex Pharmaceuticals (Etats—Unis) et Eurofins (Luxembourg).
Actualités en fusion/acquisition en Biotechnologie.
- Eli Lilly has announced the acquisition of AtaiBeckley (publié le 17 juillet 2026).
- GSK a acquis Nuvalent (publié le 17 juillet 2026).
- Clearside Biomedical has gone out of its bankruptcy protection (publié le 15 juillet 2026).
Contacts en Biotechnologie
Actualités
Derniers communiqués de presse par Pharming
- Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders
- Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
- Pharming Group to participate in Fireside Chat at 2026 Jefferies Global Healthcare Conference in New York
- Pharming Group announces results of 2026 Annual General Meeting of Shareholders
- Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders
- Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026
- Pharming Group to report first quarter 2026 financial results and provide business update on May 7
- Pharming Group announces the 2026 Annual General Meeting of Shareholders
- Pharming Group to participate in April investor conferences
- Pharming Group announces the filing of its 2025 Annual Report and Form 20-F
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Pharming
- Pharming sur Wikipédia, Google News & Yahoo Finance en 1-click
- Pharming sur LinkedIn, X (Twitter) & YouTube en 1-click
